BIOLASE Inc. Shares Close the Day 10.5% Lower - Daily Wrap

The company saw its shares close the day 10.5% lower than yesterday, with trading volume lower than its 30 day average.

Mar 24, 2021 by Kwhen Finance Editors

BIOLASE Inc. Shares Close the Day 10.5% Lower - Daily Wrap
BIOLASE Inc. shares closed today 10.5% lower than it did at the end of yesterday. The stock is currently up 106.1% year-to-date, up 62.0% over the past 12 months, and down 88.5% over the past five years. Today, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.6%.

Trading Activity

  • Shares traded as high as $1.02 and as low as $0.83 this week.
  • Shares closed 4e+1% below its 52-week high and 3e+2% above its 52-week low.
  • Trading volume this week was 2.3% higher than the 10-day average and 29.5% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 2.8.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.
  • The stock closed at 9.2% lower than its 5-day moving average, 8.1% lower than its 20-day moving average, and 14.2% higher than its 90-day moving average.

Fundamentals & Catalysts

  • Over the past 12 months the company generated $-15,263,500 in earnings before interest and taxes from $24 million in revenue. It currently holds $18 million in cash and $21 million in debt.
  • Its forward price-to-earnings (P/E) ratio of -9.071999864816668 is lower than its current P/E ratio of -3.96, implying that analysts are expecting an increase in earnings.
  • The company's price/earnings-to-growth ratio (PEG Ratio), a widely used indicator of a stock's true value while also factoring in expected earnings growth, currently stands at -0.15. A fairly valued company should have a PEG ratio of 1.0. When a company's PEG exceeds 1.0, it's considered overvalued while a stock with a PEG of less than 1.0 is considered undervalued.
  • The company's debt-to-equity ratio, which measures the extent to which it finances its operations through debt, currently stands at 3.03 which means it currently has $3.03 of debt for every $1 of equity. Generally speaking, a debt to equity ratio below 1.0 is seen as relatively safe, while ratios of 2.0 or higher would be considered risky. Some industries are known for having much higher debt to equity ratios than others.
  • The company's price-to-book ratio, which measures the market's valuation of a company relative to its book value, currently stands at 9.66. This means that the stock is trading at a premium of 10 times relative to the company's book value which reflects the total value of a company's assets that shareholders of that company would receive if the company were to be liquidated.
  • The company's price-to-sales ratio, which shows how much the market values every dollar of the company's sales, currently stands at 5.42.
  • The company's enterprise value-to-revenue multiple, which is often used to determine a company's valuation in the case of a potential acquisition, currently stands at 5.31.

P/E

-3.96

EBITDA

$-15,263,500

P/Book

9.66

Mkt Cap

$125M

P/Sales

5.42

Revenue

$24M

EPS (TTM)

-0.71

PEG Ratio

-0.15

EV/Revenue

5.31

Total Cash

$18M

Debt/Equity

3.03

Forward P/E

-9.07

Current Debt

$21M

Gross Profit

$8M

Dividend Date

-

Earnings Date

2021-03-25

Profit Margin

-1.29

Revenue/Share

0.17

Total Revenue

$24M

Enterprise Val

$129M

Put/Call Ratio

0.00

Revenue/Employee

173.35

Market Comparative Performance

  • The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company share price lags the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
BIOLASE Inc.-10.5106.162.0-39.7331.3
Dow Jones Industrial Average1.47.156.9-1.461.3
S&P 500 Index1.64.660.4-1.562.9
Health Care1.91.144.6-3.841.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 10659.4%
  • The company's stock price performance over the past 12 months lags the peer average by -39.9%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
BIOLASE Inc.BIOL-4.0106.162.0-39.7331.3
Peer AvgN/A-39.61.0103.2-19.7136.3
Align Technology Inc.ALGN23.5-1.1175.7-18.2245.0
DENTSPLY SIRONA Inc.XRAY-161.717.256.8-5.175.3
Pro-Dex Inc.PDEX19.4-13.177.1-35.988.6

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: